TITLE

Anticholinergic drugs: response of parkinsonism not responsive to levodopa

AUTHOR(S)
Yamada, H.; Momose, T.; Okada, M.; Kuroiwa, Y.
PUB. DATE
January 2002
SOURCE
Journal of Neurology, Neurosurgery & Psychiatry;Jan2002, p111
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
66345913

 

Related Articles

  • Drug treatment of Parkinson's disease. Quinn, Niall // BMJ: British Medical Journal (International Edition);3/4/95, Vol. 310 Issue 6979, p575 

    Focuses on drugs available for treating Parkinson's disease. Anticholinergics; Amantadine; Levodopa; Dopamine agonists; Selegiline; Catechol O-methyl transferase.

  • Levodopa: long-term impact on Parkinson's disease.  // British Medical Journal (Clinical Research Edition);2/7/1981, Vol. 282 Issue 6262, p417 

    Examines the effect of levodopa on Parkinson's disease. Application of belladonna alkaloids or synthetic anticholinergic drugs; Changes in the characteristics of the patients brain; Depletion of cholinergic neurons in Alzheimer's dementia.

  • Comparisons of therapeutic effects of levodopa, levodopa and selegiline, and bromocriptine in patients with early, mild Parkinson's disease: three year interim report. Lees, A.J. // BMJ: British Medical Journal (International Edition);8/21/93, Vol. 307 Issue 6902, p469 

    Compares the therapeutic effects of levodopa, selegiline and bromocriptine for the treatment of Parkinson's disease in Great Britain. Baseline characteristics of the three drugs; Adverse reactions of levodopa and selegiline; Therapeutic response of bromocriptine.

  • Delayed early morning turn "ON" in response to a single dose of levodopa in advanced Parkinson's disease: pharmacokinetics should be considered. Chciná, P.; Kuntsmann, C.; Reyes-Parada, M.; Sáez-Briones, P. // Journal of Neurology, Neurosurgery & Psychiatry;Dec2004, Vol. 75 Issue 12, p1782 

    Presents a letter to the editor on response to a single dose of levodopa in advanced Parkinson's disease.

  • Levodopa and the Progression of Parkinson's Disease. Walton-Hadlock, Janice L. // New England Journal of Medicine;3/31/2005, Vol. 352 Issue 13, p1386 

    A letter to the editor is presented in response to a study on levodopa and the progression of Parkinson's Disease by the Parkinson Study Group in the December 9, 2004 issue.

  • Alternatives to levodopa.  // British Medical Journal;5/15/1976, Vol. 1 Issue 6019, p1169 

    Focuses on the efficacy of levodopa for treating Parkinson's disease in Great Britain. Response of the patients to the treatment; Impact of the severe depletion of striatal dopa decarboxylase on the therapeutic effect of levodopa; Usefulness of dopamine agonists in conditions associated with...

  • Levodopa/carbidopa/valproic acid.  // Reactions Weekly;8/10/2013, Issue 1465, p25 

    An abstract of the article "Valproic acid-induced parkinsonism: Levodopa responsiveness with dyskinesia," by M. Silver and colleagues is presented.

  • Levodopa.  // Reactions Weekly;May2014, Vol. 1503 Issue 1, p26 

    An abstract of the article "Serotonergic mechanisms responsible for levodopa-induced dyskinesias in Parkinson's disease patients," by M. Politis and colleagues is presented.

  • Selegiline Delays Progression of Early Parkinson's. Raub, William // JAMA: Journal of the American Medical Association;1/5/90, Vol. 263 Issue 1, p21 

    Announces the approval of the monamine oxidase inhibitor selegiline by the U.S. Food and Drug Administration. Role of selegiline as an adjunctive treatment; Use for patients with Parkinson's disease that exhibit deterioration in response quality to levodopa and carbidopa therapy; Design of...

  • Bladder and bowel dysfunction in Parkinson’s disease. Sakakibara, R.; Uchiyama, T.; Yamanishi, T.; Shirai, K.; Hattori, T. // Journal of Neural Transmission;Mar2008, Vol. 115 Issue 3, p443 

    Bladder dysfunction (urinary urgency/frequency) and bowel dysfunction (constipation) are common non-motor disorders in Parkinson’s disease (PD). In contrast to motor disorder, the pelvic autonomic dysfunction is often non-responsive to levodopa treatment. Brain pathology mostly accounts...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics